NCT01732861 2019-12-20Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic LymphomaCelgenePhase 1 Completed20 enrolled
NCT01744626 2016-04-19Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCelgene CorporationPhase 1 Completed40 enrolled